Pharmaceutical company that produces a generic version of naloxone.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Teva Pharmaceutical Industries Ltd. in the last 30 days yet.
The 2 sources with the most insights about Teva Pharmaceutical Industries Ltd. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Increasing public scrutiny and social media backlash regarding the ethics of medicating children could lead to reputational risks and lower long-term demand.
As the opioid crisis expands globally, the market for harm reduction solutions like naloxone is expected to grow, creating opportunities for producers of generic versions.
Increasing public scrutiny and social media backlash regarding the ethics of medicating children could lead to reputational risks and lower long-term demand.
As the opioid crisis expands globally, the market for harm reduction solutions like naloxone is expected to grow, creating opportunities for producers of generic versions.
Other assets that creators frequently mention in the same content as Teva Pharmaceutical Industries Ltd..
The most active sources covering Teva Pharmaceutical Industries Ltd. (TEVA) on Kazuha are @notthreadguy, The Wall Street Journal & Spotify Studios. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Teva Pharmaceutical Industries Ltd. (TEVA) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Teva Pharmaceutical Industries Ltd. (TEVA) most frequently also discuss PFE, ROG.SW, EBS, TAK. See the "Discussed alongside" section above for full asset pages.